BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7010380)

  • 1. Can otitis media be prevented with pneumococcal vaccine?
    Mäkelä PH; Karma P
    Prog Clin Biol Res; 1980; 47():95-106. PubMed ID: 7010380
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumococcal vaccine and otitis media in infancy.
    Mäkelä PH; Karma P; Leinonen MK
    Bull Eur Physiopathol Respir; 1983; 19(2):235-8. PubMed ID: 6871501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination trials in otitis media: experiences in Finland since 1977.
    Mäkelä PH; Karma P
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S79-82. PubMed ID: 2648300
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination against pneumococci].
    Wiedermann G
    Wien Med Wochenschr; 1982 Oct; 132(20):479-84. PubMed ID: 7157810
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of Streptococcus pneumoniae and influenza virus vaccines in the chinchilla otitis media model.
    Giebink GS
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S42-4. PubMed ID: 2648295
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide.
    Giebink GS; Berzins IK; Schiffman G; Quie PG
    J Infect Dis; 1979 Nov; 140(5):716-23. PubMed ID: 43345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otitis media: prospects for prevention.
    Haggard M
    Vaccine; 2008 Dec; 26 Suppl 7():G20-4. PubMed ID: 19094934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against acute otitis media].
    Veenhoven RH; van den Berg YL; Schilder AG; Dhooge IJ; Rijkers GT; Sanders EA
    Ned Tijdschr Geneeskd; 2000 May; 144(20):931-4. PubMed ID: 10827848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
    Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal vaccine in otitis media.
    Mäkelä PH; Karma P
    Lancet; 1981 Jan; 1(8212):152-3. PubMed ID: 6109824
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumococcal otitis media vaccine trials.
    Klein JO
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S82-3. PubMed ID: 2648301
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of pneumococcal capsular types causing pediatric infections.
    Austrian R
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S21-2. PubMed ID: 2648289
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of new pneumococcal vaccines: the Finnish approach.
    Eskola J; Takala AK; Kilpi TM; Lankinen KS; Käyhty H
    Dev Biol Stand; 1998; 95():85-92. PubMed ID: 9855418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of pneumococcal vaccine.
    Le C
    JAMA; 2000 Jul; 284(4):440; author reply 440-1. PubMed ID: 10904499
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of antibiotic resistance for management of acute otitis media.
    Klein JO
    J Lab Clin Med; 2000 Mar; 135(3):220-4. PubMed ID: 10711859
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.
    Barnett ED; Pelton SI; Cabral HJ; Eavey RD; Allen C; Cunningham MJ; McNamara ER; Klein JO
    Clin Infect Dis; 1999 Jul; 29(1):191-2. PubMed ID: 10433584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.